Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

AB0243 ASSOCIATIONS BETWEEN JOINT DEFORMITY, DISEASE DURATION, DISEASE ACTIVITY, ACTIVITIES OF DAILY LIVING, QUALITY OF LIFE, PAIN, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Autor: I. Yoshii, N. Sawada, T. Chijiwa

Publikováno v: Annals of the Rheumatic Diseases. 81:1249.1-1249

BackgroundPatient with rheumatoid arthritis (RA) have disease-related problems such as joint deformity, disease duration, disease activity, activities in daily life (ADL), quality of life, pain, and fatigue. All these problems correlate interactively

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cca17d770f4758a4a20c7d3208fc6931
https://doi.org/10.1136/annrheumdis-2022-eular.608

Zobrazit plný text záznamu

AB0158 PREDICT OF PROGNOSIS AT ONE YEAR AFTER THE ADMINISTRATION WITH b/tsDMARD FOR PATIENT WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS

Autor: I. Yoshii, N. Sawada, T. Chijiwa

Publikováno v: Annals of the Rheumatic Diseases. 81:1209.2-1210

BackgroundPatients with difficult-to-treat rheumatoid arthritis (D2T RA) are the most serious problem in recent systemic RA treatment protocols [1].ObjectivesPrognosis after biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::332a7d1b8e39c4406da915919ad53fd8
https://doi.org/10.1136/annrheumdis-2022-eular.203

Zobrazit plný text záznamu

AB0236 PRESENCE OF ANTI-CITRULLINATED POLYPEPTIDE ANTIBODIES DECREASES BONE MINERAL DENSITY IN BODY OF PATIENT WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY

Autor: I. Yoshii, N. Sawada

Publikováno v: Annals of the Rheumatic Diseases. 81:1246.1-1246

BackgroundPresence of anti-citrullinated polypeptide antibodies (ACPA) is one risk factor of bone erosion of the joint in patients with rheumatoid arthritis (RA). However, bone absorption in the whole body is still not clarified in a longitudinal stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e3fe590174ed9ce6b185e7a2331e5fa
https://doi.org/10.1136/annrheumdis-2022-eular.234

Zobrazit plný text záznamu

AB0383 COMPARISON OF EFFICACY AND SAFETY IN JAK INHIBITOR DUE TO A DIFFERENCE OF SELECTIVITY – TOFACITINIB vs. BARICITINIB –

Autor: I. Yoshii, N. Sawada, T. Chijiwa

Publikováno v: Annals of the Rheumatic Diseases. 81:1318.2-1319

BackgroundEach Janus Kinase Inhibitor (JAK-i) has different selectivity of JAKs, such as JAK1, JAK2, JAK3, and TIK2. However, little has been known regarding mode of action due to the selectivity difference in clinical practice for treating rheumatoi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79d01f0fd6db61d7ceb41e9b0de5a0b3
https://doi.org/10.1136/annrheumdis-2022-eular.129

Zobrazit plný text záznamu

AB1007 CLINICAL SIGNIFICANCE OF SERUM CREATININE-TO-CYSTATIN C RATIO AS A SURROGATE MARKER FOR INCIDENT OSTEOPOROTIC FRACTURE

Autor: I. Yoshii, N. Sawada, T. Chijiwa

Publikováno v: Annals of the Rheumatic Diseases. 81:1627.1-1627

BackgroundIn a previous article, we introduced a novel index of osteoporosis that represented as T-score ≤ -2.5, which constituted the combined criteria of age, serum creatinine-to-cystatin C ratio (Cr/CysC), and tartrate-resistant acid phosphatase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::de28d26aa895d091a68a07574e3997f2
https://doi.org/10.1136/annrheumdis-2022-eular.107

Zobrazit plný text záznamu

POS0554 CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN PRE-DIFFICULT-TO-TREAT STATUS

Autor: I. Yoshii, N. Sawada, T. Chijiwa

Publikováno v: Annals of the Rheumatic Diseases. 81:541.3-542

BackgroundPatients with rheumatoid arthritis (RA) who have a difficult-to-treat condition (D2T RA) are often a burden to both patients and rheumatologists.ObjectivesThe aim of this study was to determine the risk factors for failure to treat in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0261e39f9e01417526ef5de018f9a2f8
https://doi.org/10.1136/annrheumdis-2022-eular.3414

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

AB0102 EVALUATOR’S GLOBAL ASSESSMENT REFLECTS DISEASE ACTIVITY BUT NOT LINEARLY CORRELATES WITH DAILY ACTIVITY OR QUALITY OF LIFE COMPARED TO PATIENT’ GLOBAL ASSESSMENT

Autor: I. Yoshii

Publikováno v: Annals of the Rheumatic Diseases. 80:1079.2-1079

Background:Evaluator’s global assessment (EGA) is the one component of indexed disease activity evaluation assessed by the rheumatologist for treatment of rheumatoid arthritis (RA). It does not included in the Boolean remission criteria nor 28-join

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45f8860183a21bdcd1fdb02bd015526f
https://doi.org/10.1136/annrheumdis-2021-eular.320

Zobrazit plný text záznamu

AB0606 IMPACT OF ABDOMINAL AORTIC CALCIFICATION AND SERUM CREATININE-TO-CYSTATIN C RATIO TO BONE FRAGILITY FRACTURE

Autor: I. Yoshii

Publikováno v: Annals of the Rheumatic Diseases. 80:1339.1-1339

Background:Relationship between bone fragility fracture (BFF) and abdominal aortic calcification (AAC) has been discussed in recent decade.Objectives:Now we investigated the relationship between the two and a new factor of BFF: serum creatinine-to cy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8671ee2fff33e6c34de3944419d65170
https://doi.org/10.1136/annrheumdis-2021-eular.269

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání